Fernández-Olavarría A,
Mosquera-Pérez R, Díaz-Sánchez RM, Serrera- Figallo MA, Gutiérrez-Pérez JL,
Torres-Lagares D. The role of serum biomarkers in the diagnosis and prognosis
of oral cancer: A systematic review. J Clin Exp Dent. 2016;8(2):e184-93.
doi:10.4317/jced.52736
References
|
1.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59:225-49. |
|
|
|
|
|
2. Tanaka T, Ishigamori R.
Understanding carcinogenesis for fighting oral cancer. J Oncol. 2011;2011:603740. |
|
|
|
|
|
3. Mishra R. Biomarkers of
oral premalignant epithelial lesions for clinical application. Oral Oncol.
2012;48:578-84. |
|
|
|
|
|
4.
Kademani D. Oral cancer. Mayo Clin Proc. 2007;82:878-87. |
|
|
|
|
|
5.
Gupta PC, Murti PR, Bhonsle RB, Mehta FS, Pindborg JJ. Effect of cessation of tobacco use on the incidence
of oral mucosal lesions in a 10-yr follow-up study of 12,212 users. Oral Dis. 1995;1:54-8. |
|
|
|
|
|
6. Bundgaard T, Bentzen
SM, Wildt J. The prognostic effect of tobacco and alcohol consumption in
intra-oral squamous cell carcinoma. Eur J Cancer B Oral Oncol. 1994;30B:323-8. PMid:7703801 |
|
|
|
|
|
7. Sawant SS, Zingde SM,
Vaidya MM. Cytokeratin fragments in the serum: Their utility for the
management of oral cancer. Oral Oncol. 2008;44:722-32. |
|
|
|
|
|
8. Bijian
K, Mlynarek
AM, Balys
RL, Jie
S, Xu
Y, Hier
MP, et al. Serum proteomic approach for the identification
of serum biomarkers contributed by oral squamous cell carcinoma and host
tissue microenvironment. J Proteome Res. 2009;8:2173-85. |
|
|
|
|
|
9. Cordes C, Von Lingen J,
Gorogh T, Ambrosch P, Gottschlich S, Hoffmann M. Molecular and immunological
aspects of p53 and p53-autoantibodies in head and neck squamous cell
carcinoma. Oncol
Rep. 2009;22:1299-303. |
|
|
|
|
|
10. Kato H, Torigoe T.
Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Cancer.
1977;40:1621-8. PMid:332328 |
|
|
|
|
|
11. Hoffmann-Fazel A,
Hoffmann M, Gottschlich S, Maass JD, Rudert H, Maune S. Cyfra 21-1 in
diagnosis of distant metastases of head and neck carcinoma. Anticancer Res.
2003;23:917-20. |
|
|
|
|
|
12. Joshi M, Patil R.
Estimation and comparative study of serum total sialic acid levels as tumor
markers in oral cancer and precancer. J Cancer Res Ther. 2010;6:263-6. |
|
|
|
|
|
13. Doweck I, Barak M, Uri
N, Greenberg E. The prognostic value of the tumour marker cyfra 21-1 in
carcinoma of head and neck and its role in early detection of recurrent
disease. Br J Cancer. 2000;83:1696-701. |
|
|
|
|
|
14. Clementini M, Morlupi
A, Agrestini C, Barlattani A. Immediate versus delayed positioning of dental
implants in guided bone regeneration or onlay graft regenerated areas: A
systematic review. Int J Oral Maxillofac Surg. 2013;42:643-50. |
|
|
|
|
|
15. Chang
KP, Wu
CC, Fang
KH, Tsai
CY, Chang
YL, Liu
SC, et
al. Serum levels of chemokine (C-X-C motif) ligand 9
(CXCL9) are associated with tumor progression and treatment outcome in
patients with oral cavity squamous cell carcinoma. Oral Oncol. 2013;49:802-7. |
|
|
|
|
|
16. Chang KP, Chang YT, Liao CT, Yen
TC, Chen
IH, Chang
YL. Prognostic cytokine markers in peripheral blood
for oral cavity squamous cell carcinoma identified by multiplexed
immunobead-based profiling. Clin Chim Acta. 2011;412:980-7. |
|
|
|
|
|
17.
Inal E, Laçin M, Asal K, Ceylan A, Köybaşioğlu A, Ileri F, et
al. The significance of ferritin, lipid-associated
sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1
levels in SCC of the head and neck. Kulak Burun Bogaz Ihtis Derg. 2004;12:23-30. |
|
|
|
|
|
18. Madsen EL, Rissanen A, Bruun JM, Skogstrand
K, Tonstad
S, Hougaard
DM, et al. Weight loss larger than 10% is needed for
general improvement of levels of circulating adiponectin and markers of
inflammation in obese subjects: A 3-year weight loss study. Eur J
Endocrinol. 2008;158:179-87. |
|
|
|
|
|
19.
Guo XH, Wang JY, Gao Y, Gao M, Yu GY, Xiang RL, et al. Decreased adiponectin level is associated with
aggressive phenotype of tongue squamous cell carcinoma. Cancer Sci.
2013;104:206-13. |
|
|
|
|
|
20. Perretti M, Flower RJ.
Annexin 1 and the biology of the neutrophil. J Leukoc Biol. 2004;76:25-9. |
|
|
|
|
|
21. Faria PC, Sena AA, Nascimento R, Carvalho
WJ, Loyola
AM, Silva
SJ. Expression of annexin A1 mRNA in peripheral blood
from oral squamous cell carcinoma patients. Oral Oncol. 2010;46:25-30. |
|
|
|
|
|
22. Feng XY, Li JH, Li JZ,
Han ZX, Xing RD. Serum SCCA, cyfra 21-1, EGFR and cyclin D1 levels in
patients with oral squamous cell carcinoma. Int J Biol Markers. 2010;25:93-8. |
|
|
|
|
|
23. Capaccio P, Pruneri G,
Carboni N, Pagliari AV, Quatela M, Cesana BM, Pignataro
L. Cyclin D1 expression is predictive of occult metastases in head and neck
cancer patients with clinically negative cervical lymph nodes. Head Neck.
2000;22:234-40. PMid:10748446 |
|
|
|
|
|
24. Khandavilli SD,
Ceallaigh PO, Lloyd CJ, Whitaker R. Serum C-reactive protein as a prognostic
indicator in patients with oral squamous cell carcinoma. Oral Oncol.
2009;45:912-4. |
|
|
|
|
|
25. Tu HF, Liu CJ, Liu SY,
Chen YP, Yu EH, Lin SC, et al. Serum decoy receptor 3 level: A predictive
marker for nodal metastasis and survival among oral cavity cancer patients.
Head Neck. 2011;33:396-402. PMid:20645287 |
|
|
|
|
|
26. Zhang L, Yang X, Pan HY, Zhou
XJ, Li
J, Chen
WT, et al. Expression of growth differentiation factor
15 is positively correlated with histopathological malignant grade and in
vitro cell proliferation in oral squamous cell carcinoma. Oral Oncol. 2009;45:627-32. |
|
|
|
|
|
27. Schiegnitz E, Kammerer
PW, Koch FP, Kruger M, Berres M, Al-Nawas B. GDF 15 as an anti-apoptotic,
diagnostic and prognostic marker in oral squamous cell carcinoma. Oral Oncol.
2012;48:608-14. |
|
|
|
|
|
28. Cordella C, Luebbers
HT, Rivelli V, Gratz KW, Kruse AL. An evaluation of the preoperative
hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck
Oncol. 2011;3:35. PMid:21843350 |
|
|
|
|
|
29. Dinarello CA. Biologic
basis for interleukin-1 in disease. Blood. 1996;87:2095-2147. |
|
|
|
|
|
30.
Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, et al. Salivary and serum interleukin 1 beta, interleukin 6
and tumor necrosis factor alpha in patients with leukoplakia and oral cancer.
Med Oral Patol Oral Cir Bucal. 2012;17:e10-5. |
|
|
|
|
|
31. Watson NF, Spendlove I, Madjd Z, McGilvray R, Green AR, Ellis IO,
et al. Expression of the
stress-related MHC class I chain-related protein MICA is an indicator of good
prognosis in colorectal cancer patients. Int J Cancer. 2006;118:1445-1452. |
|
|
|
|
|
32. Tamaki S, Kawakami M,
Ishitani A, Kawashima W, Kasuda S, Yamanaka Y, et al. Soluble MICB serum
levels correlate with disease stage and survival rate in patients with oral
squamous cell carcinoma. Anticancer Res. 2010;30:4097-101. |
|
|
|
|
|
33. Liu CJ, Chang KW, Lin
SC, Cheng HW. Presurgical serum levels of matrix metalloproteinase-9 and
vascular endothelial growth factor in oral squamous cell carcinoma. Oral
Oncol. 2009;45:920-5. |
|
|
|
|
|
34. Tadbir
AA, Purshahidi
S, Ebrahimi
H, Khademi
B, Malekzadeh
M, Mardani
M, et al. Serum level of MMP-3 in patients with oral
squamous cell carcinoma--lack of association with clinico-pathological
features. Asian Pac J Cancer Prev. 2012;13:4545-8. |
|
|
|
|
|
35. Rao VR, Krishnamoorthy
L, Kumaraswamy SV, Ramaswamy G.Circulating levels in
serum of total sialic acid, lipid-associated sialic acid, and fucose in
precancerous lesion and cancer of the oral cavity. Cancer Detect Prev. 1998;22:237-40. |
|
|
|
|
|
36. Rajpura KB, Patel PS,
Chawda JG, Shah RM. Clinical significance of total and lipid bound sialic
acid levels in oral pre-cancerous conditions and oral cancer. J Oral Pathol
Med. 2005;34:263-7. |
|
|
|
|
|
37. Li C, Zhao Y, Zhang W,
Zhang W. Increased prevalence of T(H)17 cells in the
peripheral blood of patients with head and neck squamous cell carcinoma. Oral
Surg Oral Med Oral Pathol Oral Radiol Endod. 201;112:81-9.
http://dx.doi.org/10.1016/j.tripleo.2010.11.032 |
|
|
|
|
|
38. Sawant
SS, Chaukar
DA, Joshi
SS, Dange
PP, Kannan
S, Kane
S, et al. Prognostic value of tissue polypeptide
antigen in oral squamous cell carcinoma. Oral Oncol. 2011;47:114-120. |
|
|
|
|
|
39. Shang ZJ, Li JR, Li
ZB. Circulating levels of vascular endothelial growth factor in patients with
oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2002;31:495-8. |
|